Other languages Allakos Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-02 EDT			5-day change	1st Jan Change
1.1 ^USD	-2.65%		+7.84%	-59.71%

03-15	North American Morning Briefing : Inflation Worries Continue to Weigh on Mood	DJ
03-14	Allakos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Allakos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-14
Allakos Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-14
Allakos Inc. Announces Publication Highlighting AK006 Mast Cell Inhibition	02-12
Sector Update: Health Care Stocks Slipping Late Afternoon	01-17
Sector Update: Health Care	01-17
Top Midday Decliners	01-17
Allakos Shares Fall After Downgrades by Jefferies, Cantor Fitzgerald, Lifesci Capital	01-17
Sector Update: Health Care Stocks Weaker Late Afternoon	01-16
Sector Update: Health Care Stocks Softer Tuesday Afternoon	01-16
Sector Update: Health Care	01-16
Allakos to Cut Workforce in Restructuring After Lirentelimab Trials Fail to Meet Targets; Shares Drop	01-16
Traders Digest More Bank Earnings, Fueling Narrow Premarket Losses for US Equity Futures	01-16
Allakos to stop further development of skin disease drug, plans job cuts	01-16
Allakos says experimental skin disease drug fails mid-stage studies	01-16
Allakos Announces Restructuring to Focus on Development of AK006	01-16
Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints	01-16
Allakos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13
Allakos Inc. Appoints Neil Graham to its Board of Directors	23-08-30
Allakos Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09
Allakos Inc. Announces Board Appointments	23-08-03

No results for this search